Named as a key player in 50 of our reports, across 50 regions and countries.
Our reports that name Euroimmun as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Euroimmun (number of shared markets).
Bio-Rad Laboratories1 shared market
Roche1 shared market
Siemens Healthineers1 shared market
Thermo Fisher Scientific Inc.1 shared market
Werfen1 shared market
The topics of the markets Euroimmun is in.
Stories on the topics Euroimmun works in.
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
COVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Read